Gilead HIV drug not entitled to SPC, says UK court

20-09-2018

Gilead HIV drug not entitled to SPC, says UK court

marianvejcik / iStockphoto.com

The English High Court has ruled that Gilead’s drug Truvada is not entitled to a supplementary protection certificate (SPC) because it failed to meet the standards set out by Europe’s highest court earlier this year.


supplementary protection certificate, SPC, patent, HIV, generics, Truvada, English High Court, Mr Justice Arnold, Gilead, Teva, Accord Healthcare, Mylan

LSIPR